Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
CEO: Payman Khales. Company website
Integer Holdings Corporation (ITGR) trades at $126.28, down 0.04% on the day, as of Sep 20, 2026 15:01 UTC.
Integer Holdings Corporation has a market capitalisation of $4.29B, calculated from the live ITGR share price and shares outstanding.
ITGR trades at a trailing P/E of 34.50, from earnings per share of $3.66 over the last twelve months.
Integer Holdings Corporation generated revenue of $1.84B over the trailing twelve months, which puts the stock at 2.33 times sales.
ITGR has traded between $62.00 and $126.80 over the past 52 weeks, and the last price is 0.4% below that high.
Yes. Integer Holdings Corporation keeps 6.97% of revenue as net income over the trailing twelve months.
Wall Street analysts rate ITGR Buy, with an average price target of $118.25, 6.4% below the current price.
Integer Holdings Corporation is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.
Payman Khales is the chief executive of Integer Holdings Corporation, which employs 11,000 people.
QFI Terminal shows ITGR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ITGR in Terminal See plans